摘要
目的探讨孟鲁司特钠治疗儿童感染后咳嗽的临床效果。方法将本院收治的125例咳嗽感染后患儿分为治疗组62例和对照组63例,对照组给予氯雷他定联合抗生素(阿奇霉素)治疗,治疗组给予氯雷他定联合孟鲁司特钠治疗。比较两组患儿的临床疗效和VAS评分。结果治疗组患儿的总有效率为93.5%,明显高于对照组的60.3%,两组间比较,差异有统计学意义(χ2=8.875,P<0.05)。两组患儿治疗前VAS评分差异无统计学意义(P>0.05);治疗后1周VAS评分改善率治疗组明显优于对照组,两组间差异有统计学意义(P<0.05)。结论孟鲁司特钠治疗儿童感染后咳嗽疗效显著,值得临床推广。
Objective To explore the clinical effect of montelukast sodium treatment of children cough after infection. Methods One hundred and twenty-five cases of cough after infection patients were divided into treatment group （n = 62） and control group （n = 63） in our hospital, the control group was given loratadine with antibiotic （azithromyein） treated, the treatment group was given loratadine with montelukast sodium treated. The clinical curative effect and VAS score was compared between the two groups. Results The total effective rate was 93.5% in treatment group, sig- nificantly higher than that of control group （60.3%）, the difference was statistically significant between the two groups （X^2 = 8.875, P 〈 0.05）. The VAS score before treatment between the two groups had no statistically significant differ- ence （P〉 0.05）; The VAS score period after treatment 1 week in treatment group was better than that of control group, the difference was statistically significant between the two groups （P 〈 0.05）. Conclusion The curative effect is distinct in montelukast sodium treatment of children cough after infection, it is worthy of clinical promotion.
出处
《中国当代医药》
2013年第10期28-29,共2页
China Modern Medicine
基金
广东省广州市花都区科技计划项目(HD11-Y021)
关键词
孟鲁司特钠
儿童
感染
咳嗽
应用价值
Montelukast sodium
Children
Infection
Cough
Application value
